ICD10BillableValid for clinical use
ICD-10 Code J70.3: Chronic drug-induced interstitial lung disorders
Reviewed by HealthAssure Clinical TeamUpdated 26 May 2026
What is this code?
ICD-10 codes are diagnosis classification codes used in healthcare records, reporting, coding workflows, and billing support. This code sits within the broader ICD-10 area for Diseases of the respiratory system (J00-J99).
When is it used?
- May be used when a clinician documents chronic drug-induced interstitial lung disorders in a patient's medical record.
- May appear in hospital records, claims, referrals, and clinical documentation.
- This code can be used as a clinically usable diagnosis entry in standardized coding workflows.
What it does not mean
- A code alone does not explain severity, treatment plan, or outcome.
- A medical code should not be treated as a substitute for a doctor's diagnosis or advice.
Code hierarchy
chapter
10Diseases of the respiratory system (J00-J99)
block
J60-J70Lung diseases due to external agents
category
J70Respiratory conditions due to other external agents
currentJ70
Official coding notes
Applicable to
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Excludes1 (do not code together)
- interstitial pneumonia NOS (J84.9)
- lymphoid interstitial pneumonia (J84.2)
Use additional code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Where you may see this code
You may see this code in hospital records, discharge summaries, insurance claims, encounter documentation, referrals, or other healthcare billing and coding records.
Related specialists
PulmonologistGeneral Physician
Related codes
J70.0Acute pulmonary manifestations due to radiationcodeJ70.1Chronic and other pulmonary manifestations due to radiationcodeJ70.2Acute drug-induced interstitial lung disorderscodeJ70.4Drug-induced interstitial lung disorders, unspecifiedcodeJ70.5Respiratory conditions due to smoke inhalationcodeJ70.8Respiratory conditions due to other specified external agentscodeJ70.9Respiratory conditions due to unspecified external agentcode
Sibling codes
J70.0Acute pulmonary manifestations due to radiationbillableJ70.1Chronic and other pulmonary manifestations due to radiationbillableJ70.2Acute drug-induced interstitial lung disordersbillableJ70.4Drug-induced interstitial lung disorders, unspecifiedbillableJ70.5Respiratory conditions due to smoke inhalationbillableJ70.8Respiratory conditions due to other specified external agentsbillableJ70.9Respiratory conditions due to unspecified external agentbillable
Coverage-related procedures and services
CPT 94621high
CARDIOPULMONARY EXERCISE TESTING, INCLUDING MEASUREMENTS OF MINUTE VENTILATION, CO2 PRODUCTION, O2 UPTAKE, AND ELECTROCARDIOGRAPHIC RECORDINGS
Source: CMS coverage guidance
CPT 87428high
INFECTIOUS AGENT ANTIGEN DETECTION BY IMMUNOASSAY TECHNIQUE (EG, ENZYME IMMUNOASSAY [EIA], ENZYME-LINKED IMMUNOSORBENT ASSAY [ELISA], FLUORESCENCE IMMUNOASSAY [FIA], IMMUNOCHEMILUMINOMETRIC ASSAY [IMCA]), QUALITATIVE OR SEMIQUANTITATIVE; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (EG, SARS-COV, SARS-COV-2 [COVID-19]) AND INFLUENZA VIRUS TYPES A AND B
Source: CMS coverage guidance
CPT 87631high
INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); RESPIRATORY VIRUS (EG, ADENOVIRUS, INFLUENZA VIRUS, CORONAVIRUS, METAPNEUMOVIRUS, PARAINFLUENZA VIRUS, RESPIRATORY SYNCYTIAL VIRUS, RHINOVIRUS), INCLUDES MULTIPLEX REVERSE TRANSCRIPTION, WHEN PERFORMED, AND MULTIPLEX AMPLIFIED PROBE TECHNIQUE, MULTIPLE TYPES OR SUBTYPES, 3-5 TARGETS
Source: CMS coverage guidance
CPT 87636high
INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID-19]) AND INFLUENZA VIRUS TYPES A AND B, MULTIPLEX AMPLIFIED PROBE TECHNIQUE
Source: CMS coverage guidance
CPT 87637high
INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID-19]), INFLUENZA VIRUS TYPES A AND B, AND RESPIRATORY SYNCYTIAL VIRUS, MULTIPLEX AMPLIFIED PROBE TECHNIQUE
Source: CMS coverage guidance
CPT 94642high
AEROSOL INHALATION OF PENTAMIDINE FOR PNEUMOCYSTIS CARINII PNEUMONIA TREATMENT OR PROPHYLAXIS
Source: CMS coverage guidance
Mapped diagnoses and classifications
SNOMED_CT 196053000high
Chronic drug-induced interstitial lung disorders
Source: SNOMED International ICD-10 map
SNOMED_CT 1388716002high
Chronic eosinophilic pneumonia caused by medication
Source: SNOMED International ICD-10 map
SNOMED_CT 713244007high
Drug induced pulmonary fibrosis
Source: SNOMED International ICD-10 map
Coding guidelines
Compatibility
Legacy and official ICD code match exactly.
Legacy codes
J70.3
Common synonyms
Chronic drug-induced interstitial lung disorders
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from ICD-10. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.